Product Information
TERIFLUNOMIDE 7 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.6037 per EA under NDC 16729039910. Its NADAC has been published 42 times since May 22, 2024.
The High Outlier badge above means this manufacturer's average price in the Teriflunomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729039910
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
TERIFLUNOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209690On Market Since
3/13/2023
Pharmacological Classes
Price Statistics
The NADAC for TERIFLUNOMIDE 7 MG TABLET has been published 42 times since May 22, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6037 per EA |
|---|---|
| All-time high | $0.6047 (Jun 12, 2024) |
| All-time low | $0.3803 (Aug 21, 2024) |
| Median price | $0.4722 |
| Average price | $0.4877 |
| Largest weekly change | -24.0% (Aug 21, 2024) |
| Weeks tracked | 42 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TERIFLUNOMIDE 7 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERIFLUNOMIDE 7 MG TABLET, manufactured by Accord Healthcare Inc., is $0.6037 per EA (NDC 16729039910), effective Mar 5, 2025.
How has the price of TERIFLUNOMIDE 7 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERIFLUNOMIDE 7 MG TABLET has held within roughly two percent of its current level. It has been tracked across 42 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for TERIFLUNOMIDE 7 MG TABLET?
Since May 22, 2024, the NADAC for TERIFLUNOMIDE 7 MG TABLET has ranged from a low of $0.3803 (Aug 21, 2024) to a high of $0.6047 (Jun 12, 2024), with a median of $0.4722 per EA.
Are there cheaper alternatives to TERIFLUNOMIDE 7 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TERIFLUNOMIDE 7 MG TABLET, is $0.3198 per EA — about 47% below TERIFLUNOMIDE 7 MG TABLET.
Who manufactures TERIFLUNOMIDE 7 MG TABLET?
TERIFLUNOMIDE 7 MG TABLET (NDC 16729039910) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification